1
|
Yang Y, Quan Y, Liu Y, Yang J, Chen K, You X, Hua H, Yan L, Zhao J, Wang J. Exploring the potential mechanism of Xiaojin Pill therapy for benign prostatic hyperplasia through metabolomics and gut microbiota analysis. Front Microbiol 2024; 15:1431954. [PMID: 39234552 PMCID: PMC11371748 DOI: 10.3389/fmicb.2024.1431954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Accepted: 07/17/2024] [Indexed: 09/06/2024] Open
Abstract
Background Xiaojin Pill (XJP) is a traditional Chinese medicine prescribed for treating benign prostatic hyperplasia (BPH). It has been proven to have multiple effects, such as regulating sex hormone levels, exhibiting anti-tumor, anti-inflammatory, analgesic, and anti-platelet aggregation properties, and improving immunity. However, the material basis of XJP's therapeutic effect on BPH and its metabolic process in vivo remains to be clarified. At the same time, many microorganisms that exist in the urogenital tract, including those related to BPH, can also affect the health of the host. Methods Using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), the chemical components of XJP were identified. A BPH model was created through bilateral testicular ablation and injections of testosterone propionate. A comprehensive evaluation of XJP efficacy was conducted using pathological ELISA, TUNEL, and immunohistochemical techniques. In addition, UPLC-MS metabolomics and 16S rRNA sequencing revealed the serum metabolic profile and intestinal microbiota composition. We performed a Spearman correlation coefficient analysis to highlight the interactions between "intestinal microbiota-serum factors" and "intestinal microbiota-metabolites." Results XJP contains 91 compounds that alleviate pathologies of BPH in rats, decreasing prostate weight, index, and serum levels of Dihydrotestosterone (DHT), Prostate-Specific Antigen (PSA), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) levels. It inhibits prostatic epithelial cell apoptosis and downregulates Bax, TGF-β1, and IGF-1 proteins in the caspase-3 pathway. Metabolomics studies have revealed 10 upregulated and 10 downregulated metabolites in treated rats, with 5-methylcytosine, uracil, and cytosine enriched in pyrimidine metabolism. L-arginine plays a pivotal role in metabolic pathways encompassing pyrimidine metabolism, arginine biosynthesis, and the mammalian target of rapamycin (mTOR) signaling pathway. 16S rRNA sequencing revealed that XJP optimized the diversity and balance of intestinal flora in BPH rats by decreasing the Bacteroidetes/Firmicutes (B/F) ratio, enhancing the beneficial bacteria, such as Eggerthellaceae, Anaerovoracaceae, and Romboutsia, and suppressing the dysfunctional bacteria, such as Atopobiaceae, Prevotellaceae_NK3B31_group, Dorea, and Frisingicoccus. According to the Spearman correlation coefficient analysis, Lactobacillus was found to be most associated with serum factors, whereas Romboutsia showed the highest correlation with metabolites. This finding suggests that XJP modulates pyrimidine metabolism disorders in BPH rats, a regulation that aligns closely with Romboutsia, Prevotellaceae_NK3B31_group, Lactobacillus, Chujaibacter, and Enterorhabdus, thereby providing valuable biological insights. Conclusion In summary, these findings indicate that XJP possesses a synergistic anti-BHP effect through its multi-component, multi-target, multi-gut microbiota, and multi-metabolic pathway properties. The effect involves the regulation of sex hormone levels, growth factors, and the anti-epithelial cell apoptosis process. The modulation of specific gut microbiota by the host and the involvement of multiple metabolic pathways are likely one of the significant mechanisms of XJP in treating BPH. Notably, pyrimidine metabolism and the intestinal microbial ecosystem are closely intertwined in this process.
Collapse
Affiliation(s)
- Yuying Yang
- School of Pharmacy, Southwest Medical University, Luzhou, China
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
| | - Yunyun Quan
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
| | - Yunteng Liu
- College of Food and Biological Engineering, Chengdu University, Chengdu, China
| | - Juhua Yang
- College of Food and Biological Engineering, Chengdu University, Chengdu, China
| | - Keyu Chen
- Pharmacology of Chinese Medicine, Shanxi University, Xianyang, China
| | - Xiaozhou You
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
| | - Hua Hua
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
- College of Food and Biological Engineering, Chengdu University, Chengdu, China
| | - Liangchun Yan
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
| | - Junning Zhao
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
| | - Jianbo Wang
- School of Pharmacy, Southwest Medical University, Luzhou, China
- Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Key Laboratory of Biological Evaluation of Translational Chinese Medicine (TCM) Quality of National Administration of TCM, Sichuan Key Laboratory of Translational Medicine of TCM, Sichuan Authentic Medicine System Development Engineering Technology Research Center, Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center, Chengdu, China
- Pharmacology of Chinese Medicine, Shanxi University, Xianyang, China
| |
Collapse
|
2
|
Hashitani H, Takeya M, van Helden DF. Commonality and heterogeneity of pacemaker mechanisms in the male reproductive organs. J Physiol 2024. [PMID: 38607187 DOI: 10.1113/jp284756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 03/26/2024] [Indexed: 04/13/2024] Open
Abstract
During emission, the first phase of ejaculation, smooth muscle in organs of the male reproductive tract (MRT) vigorously contract upon sympathetic nerve excitation to expel semen consisting of sperm and seminal plasma. During inter-ejaculation phases, the epididymis, seminal vesicles and prostate undergo spontaneous phasic contractions (SPCs), this transporting and maintaining the quality of sperm and seminal plasma. Recent studies have revealed platelet-derived growth factor receptor α-expressing (PDGFRα+) subepithelial interstitial cells in seminal vesicles subserve the role of pacemaker cells that electrically drive SPCs in this organ. PDGFRα+ smooth muscle cells in the epididymis also appear to function as pacemaker cells implicating PDGFRα as a potential signature molecule in MRT pacemaking. The dominant mechanism driving pacemaking in these organs is the cytosolic Ca2+ oscillator. This operates through entrainment of the release-refill cycle of Ca2+ stores, the released Ca2+ ions opening Ca2+-activated chloride channels, including in some cases ANO1 (TMEM16A), with the resultant pacemaker potential activating L-type voltage-dependent Ca2+ channels in the smooth muscle causing contraction (viz. SPCs). A second pacemaker mechanism, namely the membrane oscillator also has a role in specific cases. Further investigations into the commonality and heterogeneity of MRT pacemakers will open an avenue for understanding the pathogenesis of male infertility associated with deterioration of seminal plasma.
Collapse
Affiliation(s)
- Hikaru Hashitani
- Department of Cell Physiology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan
| | - Mitsue Takeya
- Division of Integrated Autonomic Function, Department of Physiology, Kurume University School of Medicine, Kurume, Japan
| | - Dirk F van Helden
- School of Biomedical Sciences and Pharmacy, Faculty of Health, Medicine and Wellbeing & Hunter Medical Research Institute, The University of Newcastle, Callaghan, New South Wales, Australia
| |
Collapse
|
3
|
Kawaguchi Y, Ohta K, Hiroshige T, Uemura KI, Togo A, Nakamura KI, Igawa T. Sheet-like interstitial cells connect epithelial and smooth muscle cells in the mouse prostate. Acta Histochem 2024; 126:152153. [PMID: 38484443 DOI: 10.1016/j.acthis.2024.152153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2023] [Revised: 02/24/2024] [Accepted: 03/01/2024] [Indexed: 04/24/2024]
Abstract
Epithelial-stromal relationship in the prostate gland is crucial for maintaining homeostasis, including functional differentiation, proliferation, and quiescence. Pathological stromal changes are believed to cause benign prostatic hyperplasia (BPH). The prostate stromal tissue is known to have several subtypes of interstitial cells that connect the epithelium and smooth muscle. However, the characteristics of their morphology and connection patterns are not fully understood. Therefore, we aimed to investigated the three-dimensional morphology and intercellular interactions of interstitial cells in the prostate ventral lobe of mature wild-type mice using immunohistochemistry and focused ion beam-scanning electron microscopy tomography (FIB-SEM tomography). The prostate interstitial cells exhibited immunohistochemical subtypes, including PDGFRα single-positive, CD34 single-positive, and CD34 and PDGFRα double-positive. PDGFRα single-positive cells were observed as elongated cells just below the epithelium, CD34 single-positive cells were observed as polygonal cells in the area away from the epithelium, and double-positive cells were observed as elongated cells situated slightly deeper than PDGFRα single-positive cells. Furthermore, connexin43-immunoreactive puncta were observed on interstitial cells just beneath the epithelium, suggestive of possible electrical connections among the PDGFRα single-positive interstitial cells. Three-dimensional structural analysis using FIB-SEM tomography revealed sheet-like multilayered interstitial cells that appear to separate the glandular terminal from the deeper interstitial tissue, which includes smooth muscle and capillaries. Further, epithelial cells might be indirectly connected to the smooth muscle and nerve fibers via these sheet-like multilayered interstitial cellular networks. These findings suggest that the cellular network that separates the glandular terminals from the deep interstitial tissue functionally bridges the epithelium and smooth muscle, possibly playing a pivotal role in prostate tissue homeostasis through the epithelial-smooth muscle or epithelial-stromal relationships.
Collapse
Affiliation(s)
- Yoshihiro Kawaguchi
- Department of Urology, Saiseikai Futsukaichi Hospital, 3-13-1 Yu-machi, Chikushino-shi, Fukuoka 818-8516, Japan; Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume-shi, Fukuoka, Kurume 830-0011, Japan.
| | - Keisuke Ohta
- Advanced Imaging Research Center, Kurume University School of Medicine, Kurume 830-0011, Japan
| | - Tasuku Hiroshige
- Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume-shi, Fukuoka, Kurume 830-0011, Japan
| | - Kei-Ichiro Uemura
- Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume-shi, Fukuoka, Kurume 830-0011, Japan
| | - Akinobu Togo
- Advanced Imaging Research Center, Kurume University School of Medicine, Kurume 830-0011, Japan
| | - Kei-Ichiro Nakamura
- Division of Microscopic and Departmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume 830-0011, Japan
| | - Tsukasa Igawa
- Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume-shi, Fukuoka, Kurume 830-0011, Japan
| |
Collapse
|
4
|
Ahmed AM, Hussein MR. Telocytes in Cutaneous Biology: A Reappraisal. ACTAS DERMO-SIFILIOGRAFICAS 2023; 114:T229-T239. [PMID: 36690154 DOI: 10.1016/j.ad.2022.08.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 08/30/2022] [Indexed: 01/22/2023] Open
Abstract
The telocytes (TCs) are novel interstitial cells that have been overlooked for a long time due to their histologic similarity to other stromal cells. TCs can be separated from the stromal cells based on their distinct immunohistochemical, ultrastructural, and molecular features. Functionally, TCs are involved in the tissue renewal, mechanical support, and immune modulation. These cells are also involved in the signal transduction either through their direct interactions with the neighboring cells or through the paracrine signaling via extracellular vesicles. TCs are damaged in several inflammatory and fibrotic conditions such as ulcerative colitis, Crohn's disease, hepatic fibrosis, psoriasis, and systemic sclerosis. The transplantation of TCs in the damaged tissue can promote tissue regeneration. Therefore, enhancing tissue TCs either by their transplantation or by promoting their survival and growth using novel medications represents novel therapeutic strategy in the future. In this review, we addressed several aspects of TCs including their origin, distribution, morphologic features, and functions. We also discussed their involvement of the cutaneous TCs in the development various pathologic conditions.
Collapse
Affiliation(s)
- A M Ahmed
- Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egipto
| | - M R Hussein
- Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egipto.
| |
Collapse
|
5
|
Telocytes in Cutaneous Biology: A Reappraisal. ACTAS DERMO-SIFILIOGRAFICAS 2023; 114:229-239. [PMID: 36332689 DOI: 10.1016/j.ad.2022.08.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 08/24/2022] [Accepted: 08/30/2022] [Indexed: 12/13/2022] Open
Abstract
The telocytes (TCs) are novel interstitial cells that have been overlooked for a long time due to their histologic similarity to other stromal cells. TCs can be separated from the stromal cells based on their distinct immunohistochemical, ultrastructural, and molecular features. Functionally, TCs are involved in the tissue renewal, mechanical support, and immune modulation. These cells are also involved in the signal transduction either through their direct interactions with the neighboring cells or through the paracrine signaling via extracellular vesicles. TCs are damaged in several inflammatory and fibrotic conditions such as ulcerative colitis, Crohn's disease, hepatic fibrosis, psoriasis, and systemic sclerosis. The transplantation of TCs in the damaged tissue can promote tissue regeneration. Therefore, enhancing tissue TCs either by their transplantation or by promoting their survival and growth using novel medications represents novel therapeutic strategy in the future. In this review, we addressed several aspects of TCs including their origin, distribution, morphologic features, and functions. We also discussed their involvement of the cutaneous TCs in the development various pathologic conditions.
Collapse
|
6
|
Varga I, Polák Š, Kyselovič J, Kachlík D, Danišovič Ľ, Klein M. Recently Discovered Interstitial Cell Population of Telocytes: Distinguishing Facts from Fiction Regarding Their Role in the Pathogenesis of Diverse Diseases Called "Telocytopathies". MEDICINA (KAUNAS, LITHUANIA) 2019; 55:E56. [PMID: 30781716 PMCID: PMC6410178 DOI: 10.3390/medicina55020056] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Revised: 01/14/2019] [Accepted: 02/11/2019] [Indexed: 12/19/2022]
Abstract
In recent years, the interstitial cells telocytes, formerly known as interstitial Cajal-like cells, have been described in almost all organs of the human body. Although telocytes were previously thought to be localized predominantly in the organs of the digestive system, as of 2018 they have also been described in the lymphoid tissue, skin, respiratory system, urinary system, meninges and the organs of the male and female genital tracts. Since the time of eminent German pathologist Rudolf Virchow, we have known that many pathological processes originate directly from cellular changes. Even though telocytes are not widely accepted by all scientists as an individual and morphologically and functionally distinct cell population, several articles regarding telocytes have already been published in such prestigious journals as Nature and Annals of the New York Academy of Sciences. The telocyte diversity extends beyond their morphology and functions, as they have a potential role in the etiopathogenesis of different diseases. The most commonly described telocyte-associated diseases (which may be best termed "telocytopathies" in the future) are summarized in this critical review. It is difficult to imagine that a single cell population could be involved in the pathogenesis of such a wide spectrum of pathological conditions as extragastrointestinal stromal tumors ("telocytomas"), liver fibrosis, preeclampsia during pregnancy, tubal infertility, heart failure and psoriasis. In any case, future functional studies of telocytes in vivo will help to understand the mechanism by which telocytes contribute to tissue homeostasis in health and disease.
Collapse
Affiliation(s)
- Ivan Varga
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
| | - Štefan Polák
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
| | - Ján Kyselovič
- Fifth Department of Internal Medicine, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
| | - David Kachlík
- Institute of Anatomy, Second Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.
| | - Ľuboš Danišovič
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
| | - Martin Klein
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
| |
Collapse
|
7
|
Mo RJ, Han ZD, Liang YK, Ye JH, Wu SL, Lin SX, Zhang YQ, Song SD, Jiang FN, Zhong WD, Wu CL. Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8 + tumor-associated lymphocytes and poor prognosis in prostate cancer. Int J Cancer 2019; 144:3099-3110. [PMID: 30537104 DOI: 10.1002/ijc.32061] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2018] [Revised: 11/20/2018] [Accepted: 11/26/2018] [Indexed: 12/11/2022]
Abstract
To investigate immune profile consisting of stromal PD-L1 expression, inhibitory or non-T-cell inflamed tumor microenvironment that may predict response to anti-PD-L1/PD-1 immunotherapy in prostate cancer, we validated the specificity of a PD-L1 monoclonal antibody (E1L3N) and identified PD-L1 specific expression in prostatic stromal nerve cells. PD-L1 expression was analyzed in 73 primary prostate cancers and 7 castration-resistant prostate cancers (CRPC) by immunohistochemistry (IHC) and resulting data from primary prostate cancers were correlated with tumor-associated lymphocytes (TALs), clinicopathological characteristics and clinical outcome. PD-L1 was expressed in the tumor cells in only one primary prostate cancer case and none of the CRPC. However, PD-L1 was frequently observed in the nerve branches in the tumor-associated stroma (69 of 73 cases, 94.5%), supported by colocalization with axonal marker PGP9.5. FoxP3-, CD3- and CD8-positive T lymphocytes were observed in 74.6% (47/63), 98.4% (62/63) and 100% (61/61) of the cases, respectively. The density of PD-L1+ tumor-associated nerves (TANs) was inversely correlated with that of CD8+ TALs. Higher density of PD-L1+ TANs was significantly associated with biochemical recurrence (BCR) in Kaplan-Meier survival analysis (p = 0.016). In both univariate and multivariate Cox analysis, the density of PD-L1+ TANs was independently prognostic of BCR. In conclusion, PD-L1 expression is rare in prostate tumor cells but prevalent in TANs and negatively correlated with CD8+ TALs. Neuro-immunological interaction may be a contribution to immune-suppressive microenvironment. Combinatorial treatment regimen designs to neural PD-L1 and TALs should be warranted in future clinical application of anti-PD-L1/PD-1 immunotherapy in prostate cancer.
Collapse
Affiliation(s)
- Ru-Jun Mo
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Zhao-Dong Han
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Urology, The Second Affiliated Hospital, South China University of Technology, Guangzhou, China
| | - Ying-Ke Liang
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Jian-Heng Ye
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Shu-Lin Wu
- Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Sharron X Lin
- Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Yan-Qiong Zhang
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
| | - Sheng-Da Song
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
| | - Fu-Neng Jiang
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
| | - Wei-De Zhong
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.,Department of Urology, The Second Affiliated Hospital, South China University of Technology, Guangzhou, China.,Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Chin-Lee Wu
- Department of Urology and Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| |
Collapse
|
8
|
Chakrabarty B, Lee S, Exintaris B. Generation and Regulation of Spontaneous Contractions in the Prostate. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019; 1124:195-215. [PMID: 31183828 DOI: 10.1007/978-981-13-5895-1_8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Spontaneous myogenic contractions have been shown to be significantly upregulated in prostate tissue collected from men with Benign Prostatic Hyperplasia (BPH), an extremely common disorder of the ageing male. Although originally thought likely to be involved in 'housekeeping' functions, mixing prostatic secretions to prevent stagnation, these spontaneous myogenic contractions provide a novel opportunity to understand and treat BPH. This treatment potential differs from previous models, which focused exclusively on attenuating nerve-mediated neurogenic contractions. Previous studies in the rodent prostate have provided an insight into the mechanisms underlying the regulation of myogenic contractions. 'Prostatic Interstitial Cells' (PICs) within the prostate appear to generate pacemaker potentials, which arise from the summation of number of spontaneous transient depolarisations triggered by the spontaneous release of Ca2+ from internal stores and the opening of Ca2+-activated Cl- channels. Pacemaker potentials then conduct into neighbouring smooth muscle cells to generate spontaneous slow waves. These slow waves trigger the firing of 'spike-like' action potentials, Ca2+ entry and contraction, which are not attenuated by blockers of neurotransmission. However, these spontaneous prostatic contractions can be modulated by the autonomic nervous system. Here, we discuss the mechanisms underlying rodent and human prostate myogenic contractions and the actions of existing and novel pharmacotherapies for the treatment of BPH. Understanding the generation of human prostatic smooth muscle tone will confirm the mechanism of action of existing drugs, inform the identification and effectiveness of new pharmacotherapies, as well as predict patient outcomes.
Collapse
Affiliation(s)
- Basu Chakrabarty
- Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Melbourne, VIC, Australia
| | - Sophie Lee
- Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Melbourne, VIC, Australia
| | - Betty Exintaris
- Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Melbourne, VIC, Australia.
| |
Collapse
|
9
|
Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores. Sci Rep 2018; 8:14326. [PMID: 30254333 PMCID: PMC6156570 DOI: 10.1038/s41598-018-32711-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2018] [Accepted: 09/12/2018] [Indexed: 12/19/2022] Open
Abstract
The recent developments in anti-angiogenic and immunomodulatory drugs show that the tumour micro-environment (TME) becomes increasingly important in cancer research. Here we investigated the correlation between the Gleason score (GS) and the TME by comparing tissue expression profiles of steroid hormone receptors, cancer activated fibroblast (CAF) markers and vessel densities between different GS groups. Therefore, matched patient cohorts were composed for different GS (6-7-8). Tissue micro-arrays with 6 samples/patient were processed for immunohistochemistry. Stained slides were digitised, stroma and epithelium were selectively annotated, and all selected areas were quantitatively analysed for marker expression. The most striking findings were decreased stromal expression levels of several steroid hormone receptors, increased CAF-phenotypes and increased vessel densities in high GS prostate cancer compared to low GS prostate cancer and paired prostate non-tumour tissue. The present data reveal a complex correlation between prostate cancer differentiation and TME components and suggest that different GS can be associated with different possible actionable targets in the TME. The use of standardised digital image analysis tools generated robust and reproducible quantitative data, which is novel and more informative compared to the classic semi-quantitative and observer-dependent visual scoring of immunohistochemistry.
Collapse
|
10
|
Toivanen R, Shen MM. Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development 2017; 144:1382-1398. [PMID: 28400434 DOI: 10.1242/dev.148270] [Citation(s) in RCA: 117] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Prostate organogenesis is a complex process that is primarily mediated by the presence of androgens and subsequent mesenchyme-epithelial interactions. The investigation of prostate development is partly driven by its potential relevance to prostate cancer, in particular the apparent re-awakening of key developmental programs that occur during tumorigenesis. However, our current knowledge of the mechanisms that drive prostate organogenesis is far from complete. Here, we provide a comprehensive overview of prostate development, focusing on recent findings regarding sexual dimorphism, bud induction, branching morphogenesis and cellular differentiation.
Collapse
Affiliation(s)
- Roxanne Toivanen
- Departments of Medicine, Genetics and Development, Urology, and Systems Biology, Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
| | - Michael M Shen
- Departments of Medicine, Genetics and Development, Urology, and Systems Biology, Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
| |
Collapse
|
11
|
Sanches BDA, Maldarine JS, Zani BC, Tamarindo GH, Biancardi MF, Santos FCA, Rahal P, Góes RM, Felisbino SL, Vilamaior PSL, Taboga SR. Telocytes play a key role in prostate tissue organisation during the gland morphogenesis. J Cell Mol Med 2017; 21:3309-3321. [PMID: 28840644 PMCID: PMC5706570 DOI: 10.1111/jcmm.13234] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2016] [Accepted: 04/15/2017] [Indexed: 01/19/2023] Open
Abstract
Telocytes are CD34-positive interstitial cells, known to exert several functions, one of which is a role in tissue organisation, previously demonstrated by telocytes in the myocardium. The existence of telocytes in the prostate has recently been reported, however, there is a lack of information regarding the function of these cells in prostate tissue, and information regarding the possible role of these cells in prostatic development. This study used immunofluorescence techniques in prostate tissue and prostatic telocytes in culture to determine the relationship between telocytes and prostate morphogenesis. Furthermore, immunofluorescent labelling of telocytes was performed on prostate tissue at different stages of early postnatal development. Initially, CD34-positive cells are found at the periphery of the developing alveoli, later in the same region, c-kit-positive cells and cells positive for both factors are verified and CD34-positive cells were predominantly observed in the interalveolar stroma and the region surrounding the periductal smooth muscle. Fluorescence assays also demonstrated that telocytes secrete TGF-β1 and are ER-Beta (ERβ) positive. The results suggest that telocytes play a changing role during development, initially supporting the differentiation of periductal and perialveolar smooth muscle, and later, producing dense networks that separate alveoli groups and form a barrier between the interalveolar region and periurethral smooth muscle. We conclude that telocytes play a relevant role in prostate tissue organisation during postnatal development.
Collapse
Affiliation(s)
- Bruno D A Sanches
- Department of Structural and Functional Biology, State University of Campinas, Campinas, São Paulo, Brazil
| | - Juliana S Maldarine
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| | - Bruno C Zani
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| | - Guilherme H Tamarindo
- Department of Structural and Functional Biology, State University of Campinas, Campinas, São Paulo, Brazil
| | - Manoel F Biancardi
- Department of Histology, Embryology and Cell Biology, Federal University of Goiás, Goiânia, Goiás, Brazil
| | - Fernanda C A Santos
- Department of Histology, Embryology and Cell Biology, Federal University of Goiás, Goiânia, Goiás, Brazil
| | - Paula Rahal
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| | - Rejane M Góes
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| | - Sérgio L Felisbino
- Department of Morphology, Institute of Biology (IB), Univ. Estadual Paulista - UNESP, Botucatu, São Paulo, Brazil
| | - Patricia S L Vilamaior
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| | - Sebastião R Taboga
- Department of Biology, Univ. Estadual Paulista (UNESP), São José do Rio Preto, São Paulo, Brazil
| |
Collapse
|
12
|
Zheng Y, Cretoiu D, Yan G, Cretoiu SM, Popescu LM, Fang H, Wang X. Protein profiling of human lung telocytes and microvascular endothelial cells using iTRAQ quantitative proteomics. J Cell Mol Med 2015; 18:1035-59. [PMID: 25059386 PMCID: PMC4508144 DOI: 10.1111/jcmm.12350] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Accepted: 04/23/2014] [Indexed: 01/26/2023] Open
Abstract
Telocytes (TCs) are described as a particular type of cells of the interstitial space (www.telocytes.com). Their main characteristics are the very long telopodes with alternating podoms and podomers. Recently, we performed a comparative proteomic analysis of human lung TCs with fibroblasts, demonstrating that TCs are clearly a distinct cell type. Therefore, the present study aims to reinforce this idea by comparing lung TCs with endothelial cells (ECs), since TCs and ECs share immunopositivity for CD34. We applied isobaric tag for relative and absolute quantification (iTRAQ) combined with automated 2-D nano-ESI LC-MS/MS to analyse proteins extracted from TCs and ECs in primary cell cultures. In total, 1609 proteins were identified in cell cultures. 98 proteins (the 5th day), and 82 proteins (10th day) were confidently quantified (screened by two-sample t-test, P < 0.05) as up- or down-regulated (fold change >2). We found that in TCs there are 38 up-regulated proteins at the 5th day and 26 up-regulated proteins at the 10th day. Bioinformatics analysis using Panther revealed that the 38 proteins associated with TCs represented cellular functions such as intercellular communication (via vesicle mediated transport) and structure morphogenesis, being mainly cytoskeletal proteins and oxidoreductases. In addition, we found 60 up-regulated proteins in ECs e.g.: cell surface glycoprotein MUC18 (15.54-fold) and von Willebrand factor (5.74-fold). The 26 up-regulated proteins in TCs at 10th day, were also analysed and confirmed the same major cellular functions, while the 56 down-regulated proteins confirmed again their specificity for ECs. In conclusion, we report here the first extensive comparison of proteins from TCs and ECs using a quantitative proteomics approach. Our data show that TCs are completely different from ECs. Protein expression profile showed that TCs play specific roles in intercellular communication and intercellular signalling. Moreover, they might inhibit the oxidative stress and cellular ageing and may have pro-proliferative effects through the inhibition of apoptosis. The group of proteins identified in this study needs to be explored further for the role in pathogenesis of lung disease.
Collapse
Affiliation(s)
- Yonghua Zheng
- Fudan University Center for Clinical Bioinformatics, Zhongshan Hospital, Fudan University School of Medicine, Shanghai, China
| | | | | | | | | | | | | |
Collapse
|